China SXT Pharmaceuticals, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $2.2M
- Price
- $4.04
- % Change (Daily % change from the live per-ticker quote feed.)
- +11.29%
- Volume
- 3.0M
About
Established in 2005 and headquartered in Taizhou, China, China SXT Pharmaceuticals, Inc. operates as a pharmaceutical company with a comprehensive focus on traditional Chinese medicine pieces (TCMP). Its activities span the entire process, from research and development to the production, marketing, and distribution of these products across China. The company's offerings include a range of TCMP products categorized as advanced, fine, or regular, alongside a wide assortment of raw medicinal materials. Examples of these raw materials include SanQiFen, HongQi, SuMu, JiangXiang, and numerous others like ChuanBeiMu, RenShen, and JueMingZi. These products are sold under recognized brand names such as Suxuantang, Hui Chun Tang, and Tong Ren Tang. China SXT Pharmaceuticals distributes its goods to a diverse clientele, including other pharmaceutical companies, various chain pharmacies, hospitals, and specialized pharmaceutical distributors.
Quick stats
Shares outstanding534.0K
Computed float534.0K
Float / shares100.0%
Key info
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001723980
Websitehttps://www.sxtchina.com
AI Summary
AI-generated1/5
majorbearishreverse split
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
China SXT Pharmaceuticals announced a 1-for-80 consolidation of its Class A and Class B ordinary shares, effective August 10, 2026.
The reverse split will reduce the number of outstanding Class A shares from approximately 105.7 million to about 1.3 million, with fractional shares rounded up.
Shares are expected to begin trading on a post-consolidation basis on Nasdaq under the symbol 'SXTC' on August 10 with a new CUSIP number.
Red flags
- Reverse stock split ratio of 1-for-80 indicates potential listing compliance risk